Dr. Xiangyu Guo 郭翔宇
Chief Physician, Associate Professor
Department of Medical Oncology, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Chemotherapy and molecular targeted therapy for lung, breast, colorectal, gastric, pancreatic cancers, and malignant lymphoma. Supportive care for advanced cancer, including anemia, bone metastasis, chemotherapy-induced nausea and vomiting, and pain management.
Dr. Guo holds a master’s degree in oncology and has over ten years of experience in solid tumor chemotherapy. Research interests include supportive care for advanced cancer. Dr. Guo participates in two provincial research projects and has published papers in domestic core oncology journals. Proficient in Russian and English.
Professional roles
- Member and Secretary, Geriatric Oncology Professional Committee, Liaoning Life Science Society
- Member, Clinical Oncology Professional Committee (CSCO), China Anti-Cancer Association
- Member, Chinese Medical Doctor Association (CMDA)
- Member, Chemotherapy Professional Committee, Liaoning Anti-Cancer Association
Name order: in Chinese the family name comes first (Guo Xiangyu). Papers usually list the name as Xiangyu Guo or Guo X.
Selected publications
13 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Anticancer Agents Med Chem, 2024 (senior author): Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells. PubMed 38375809
- Anticancer Agents Med Chem, 2023 (senior author): Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells. PubMed 37171012
- Oncotarget, 2017 (first author): Correlation between hormone receptor status and depressive symptoms in patients with metastatic breast cancer. PubMed 28881602
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion